Literature DB >> 10594819

Characterization of a candidate Borrelia burgdorferi beta3-chain integrin ligand identified using a phage display library.

J Coburn1, W Chege, L Magoun, S C Bodary, J M Leong.   

Abstract

The spirochaetal agents of Lyme disease, Borrelia burgdorferi (sensu lato) bind to integrins alphaIIbbeta3, alphavbeta3 and alpha5beta1 in purified form and on the surfaces of human cells. Using a phage display library of B. burgdorferi (sensu stricto) DNA, a candidate ligand for beta3-chain integrins was identified. The native B. burgdorferi protein, termed p66, is known to be recognized by human Lyme disease patient sera and to be expressed on the surface of the spirochaete. We show here that recombinant p66 binds specifically to beta3-chain integrins and inhibits attachment of intact B. burgdorferi to the same integrins. When expressed on the surface of Escherichia coli, this protein increases the attachment of E. coli to a transfected cell line that expresses alphavbeta3, but not to the parental cell line, which expresses no beta3-chain integrins. Localization of p66 on the surface of B. burgdorferi, the ability of recombinant forms of the protein to bind to beta3-chain integrins and the fact that p66 and B. burgdorferi bind to beta3-chain integrins in a mutually exclusive manner make p66 an attractive candidate bacterial ligand for integrins alphaIIbbeta3 and alphavbeta3.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594819     DOI: 10.1046/j.1365-2958.1999.01654.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  70 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Borrelia burgdorferi HtrA: evidence for twofold proteolysis of outer membrane protein p66.

Authors:  James L Coleman; Alvaro Toledo; Jorge L Benach
Journal:  Mol Microbiol       Date:  2015-10-20       Impact factor: 3.501

3.  Identification of Borrelia burgdorferi outer surface proteins.

Authors:  Chad S Brooks; Santosh R Vuppala; Amy M Jett; Darrin R Akins
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans.

Authors:  Joshua R Fischer; Kimberly T LeBlanc; John M Leong
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Identification of lysine residues in the Borrelia burgdorferi DbpA adhesin required for murine infection.

Authors:  Danielle E Fortune; Yi-Pin Lin; Ranjit K Deka; Ashley M Groshong; Brendan P Moore; Kayla E Hagman; John M Leong; Diana R Tomchick; Jon S Blevins
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

6.  Protective niche for Borrelia burgdorferi to evade humoral immunity.

Authors:  Fang Ting Liang; Eric L Brown; Tian Wang; Renato V Iozzo; Erol Fikrig
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

7.  Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes.

Authors:  Aruna K Behera; Enrique Durand; Carla Cugini; Styliani Antonara; Lori Bourassa; Ethan Hildebrand; Linden T Hu; Jenifer Coburn
Journal:  Cell Microbiol       Date:  2007-09-06       Impact factor: 3.715

Review 8.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

9.  Cross-species surface display of functional spirochetal lipoproteins by recombinant Borrelia burgdorferi.

Authors:  Wolfram R Zückert; Jill E Lloyd; Philip E Stewart; Patricia A Rosa; Alan G Barbour
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Interaction of Borrelia burgdorferi Hbb with the p66 promoter.

Authors:  Melisa S Medrano; Paul F Policastro; Tom G Schwan; Jenifer Coburn
Journal:  Nucleic Acids Res       Date:  2009-11-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.